NCT06230861View on ClinicalTrials.gov

Effects of Quercetin on Cardiometabolic Outcomes

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

June 1, 2025

Conditions
Cardiometabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

Quercetin

Quercetin tablets 500mg 1 x per day

OTHER

Placebo

Placebo control 1 x blinded placebo tablet per day

Trial Locations (1)

PR4 0PE

RECRUITING

University of Central Lancashire, Preston

All Listed Sponsors
lead

University of Central Lancashire

OTHER

NCT06230861 - Effects of Quercetin on Cardiometabolic Outcomes | Biotech Hunter | Biotech Hunter